Skip to content

ClosedUnited Kingdom

Tumour Infiltrating Lymphocyte(TIL) Therapy Hubs for Melanoma(Adults)

Bids closed on 8 October 2026. The page stays for reference; similar open tenders are below.

Key facts

Country
United Kingdom
Region
UKJ1
Estimated value
not stated
Procedure
Open procedure
Published
Source
UK Find a Tender

Description

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), invited suitably qualified and experienced providers to respond to a Competitive Process for the provision of Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults). <br/><br/>Lifileucel is a first in class autologous tumour infiltrating lymphocyte (TIL) cell therapy. This infusion is followed by a short course of interleukin-2 (IL-2). IL-2 is a potent drug and has the potential to cause significant side effects. As such, it is recommended that…

Summary and why it fits you — in your account

Subscribers get a short summary in their language and an explanation of how the tender matches their searches.

Open in your account

Open on the platform: UK Find a TenderLeaves this site. Terms of participation and documents are there.

Get tenders like this every day

Save a search for the category and new tenders reach your inbox or Telegram before your competitors see them. 5 days free.

Start for free

No card. Your first saved search is already set up.